Pacific Edge Limited (PFGTF) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Pacific Edge Limited reports a steady performance for the six months ending in September 2024, despite challenges posed by Medicare uncertainties. The company’s operating revenue increased slightly, with promising developments in securing Medicare coverage for its Cxbladder tests and advancing new product launches. With a strong cash reserve, Pacific Edge remains focused on maintaining profitability and expanding its market presence.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.
